Dogwood Therapeutics, Inc.

8-K Amended charter or bylaws; Shareholder vote results Jun 17, 2026 10-Q Quarter ended 2026-03-31 May 15, 2026 8-K Results of operations (earnings release) May 14, 2026 8-K Regulation FD disclosure Mar 26, 2026 10-K Fiscal year ended 2025-12-31 Mar 18, 2026 8-K Results of operations (earnings release) Mar 18, 2026 8-K Shareholder vote results Mar 12, 2026 8-K Regulation FD disclosure Jan 20, 2026 8-K Entered a material agreement; Terminated a material agreement; Unregistered sale of equity; Regulation FD disclosure Jan 13, 2026 8-K Entered a material agreement Nov 28, 2025 8-K Director or officer change; Shareholder vote results Nov 21, 2025 10-Q Quarter ended 2025-09-30 Nov 7, 2025 8-K Results of operations (earnings release) Nov 6, 2025 8-K Regulation FD disclosure Oct 9, 2025 8-K Entered a material agreement; Unregistered sale of equity; Modified rights of security holders; Amended charter or bylaws; Regulation FD disclosure Sep 29, 2025 10-Q Quarter ended 2025-06-30 Aug 13, 2025 8-K Results of operations (earnings release) Aug 13, 2025 8-K Director or officer change Jul 2, 2025 8-K Director or officer change; Shareholder vote results Jun 24, 2025 10-Q Quarter ended 2025-03-31 May 9, 2025 8-K Results of operations (earnings release) May 8, 2025 8-K Other events Apr 3, 2025 10-K Fiscal year ended 2024-12-31 Mar 31, 2025 8-K Results of operations (earnings release) Mar 31, 2025 8-K Entered a material agreement; Other events Mar 14, 2025 8-K Entered a material agreement; Unregistered sale of equity; Modified rights of security holders; Amended charter or bylaws; Regulation FD disclosure Mar 12, 2025 8-K/A Dec 18, 2024 8-K Delisting notice or listing-rule failure Nov 21, 2024 10-Q Quarter ended 2024-09-30 Nov 8, 2024 8-K Results of operations (earnings release) Nov 7, 2024 8-K Other events Oct 30, 2024 8-K Entered a material agreement; Completed an acquisition or disposition; Unregistered sale of equity; Modified rights of security holders; Director or officer change; Amended charter or bylaws; Regulation FD disclosure; Other events Oct 7, 2024 10-Q Quarter ended 2024-06-30 Aug 9, 2024 8-K Results of operations (earnings release) Aug 8, 2024 8-K Shareholder vote results Jun 20, 2024 8-K Delisting notice or listing-rule failure Jun 12, 2024 8-K Entered a material agreement; Other events May 20, 2024 10-Q Quarter ended 2024-03-31 May 10, 2024 8-K Results of operations (earnings release) May 9, 2024 8-K Delisting notice or listing-rule failure May 7, 2024